Bagheri Alireza
Graduate School of Law, Kyoto University, Japan.
Kennedy Inst Ethics J. 2006 Sep;16(3):269-82. doi: 10.1353/ken.2006.0017.
Iran has a program of compensated kidney donation from living unrelated (LUR) donors since 1997. The aim of the program was to address the increasing demand for kidney transplantation in a morally sound manner. The program was successful in terms of increasing the number of kidneys available for transplantation. This paper presents a critical review of the program and its clinical status. Denying organ donors legitimate compensation because of the understandable fear of an organ trade is not morally justifiable, and the Iranian model of compensated LUR kidney donation offers substantial benefits that overcome these concerns. Despite its benefits, the program lacks secure measures to prevent the risk of a direct monetary relationship between donors and recipients, and it must be revised in order to be morally justifiable.
自1997年以来，伊朗实施了一项来自非亲属活体（LUR）捐赠者的有偿肾脏捐赠计划。该计划的目的是以道德合理的方式满足日益增长的肾脏移植需求。就增加可用于移植的肾脏数量而言，该计划取得了成功。本文对该计划及其临床状况进行了批判性综述。由于对器官交易的担忧可以理解而拒绝给予器官捐赠者合理补偿，这在道德上是不合理的，而伊朗的有偿非亲属活体肾脏捐赠模式提供了诸多好处，克服了这些担忧。尽管有这些好处，但该计划缺乏防止捐赠者和接受者之间直接金钱关系风险的安全措施，必须进行修订才能在道德上站得住脚。
